Related references
Note: Only part of the references are listed.Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ2R/TMEM97 ligands
Xiao-Yang Xie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Tricyclic Triazoles as σ1 Receptor Antagonists for Treating Pain
Jose Luis Diaz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Mariapaola Nitti et al.
ANTIOXIDANTS (2021)
Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects
Giuseppe Romeo et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation
Mariarita Spampinato et al.
MOLECULAR BIOLOGY REPORTS (2020)
Heme Oxygenase-1 and Carbon Monoxide Regulate Growth and Progression in Glioblastoma Cells
Carlo Castruccio Castracani et al.
MOLECULAR NEUROBIOLOGY (2020)
Antioxidation and Antiapoptosis Characteristics of Heme Oxygenase-1 Enhance Tumorigenesis of Human Prostate Carcinoma Cells
Kun-Chun Chiang et al.
TRANSLATIONAL ONCOLOGY (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
Valeria Ciaffaglione et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation
Emanuele Amata et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo
Sebastiano Intagliata et al.
AAPS JOURNAL (2020)
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers
Giuseppe Floresta et al.
BIOORGANIC CHEMISTRY (2020)
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
Roberta Listro et al.
FRONTIERS IN CHEMISTRY (2020)
Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands
Sebastiano Intagliata et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway
Jun Huang et al.
LIFE SCIENCES (2020)
Clinical Studies on Drug-Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation
Aleksi Tornio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application
Loredana Salerno et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death
Marco Raffaele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain
Thomas J. Cirino et al.
FRONTIERS IN PHARMACOLOGY (2019)
Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment
Olga Mucha et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents
Valeria Pittala et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Ginseng and heme oxygenase-1: The link between an old herb and a new protective system
Giuseppe Carota et al.
FITOTERAPIA (2019)
Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways
J. Catharina Duvigneau et al.
ANTIOXIDANTS (2019)
Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation
Sebastiano Intagliata et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
Sebastiano Intagliata et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79) Derivativess
Hilary E. Nicholson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties
Emanuele Amata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors
Loredana Salerno et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation
Khaled F. Greish et al.
MOLECULES (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Sigma-1 Receptor-Modulated Neuroinflammation in Neurological Diseases
Jia Jia et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications
Mona N. Rahman et al.
CURRENT MEDICINAL CHEMISTRY (2018)
A perspective on multi-target drug discovery and design for complex diseases
Rona R. Ramsay et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect
Emanuele Amata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform1 Inhibitors
Emanuele Amata et al.
CHEMMEDCHEM (2017)
Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer
Jeffrey D. Thomas et al.
CANCER RESEARCH (2017)
Sigma receptors [sigma Rs]: biology in normal and diseased states
Colin G. Rousseaux et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2016)
Inhibition of heme oxygenase-1 enhances the chemosensitivity of laryngeal squamous cell cancer Hep-2 cells to cisplatin
Xin Lv et al.
APOPTOSIS (2016)
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
A. L. Furfaro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature
Paramasivan Poornima et al.
PHARMACOLOGICAL RESEARCH (2016)
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Albert A. Antolin et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Potential applications for sigma receptor ligands in cancer diagnosis and therapy
Aren van Waarde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Heme oxygenase-1: emerging target of cancer therapy
Lee-Young Chau
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties
Loredana Salerno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
A Novel, Double-Clamp'' Binding Mode for Human Heme Oxygenase-1 Inhibition
Mona N. Rahman et al.
PLOS ONE (2012)
Screening of anti-glioma effects induced by sigma-1 receptor ligands: Potential new use for old anti-psychiatric medicines
Veronique Megalizzi et al.
EUROPEAN JOURNAL OF CANCER (2009)
Antiproliferative and cytotoxic effects of some σ2 agonists and σ1 antagonists in tumour cell lines
NA Colabufo et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Share Paper
